| Primary |
| Drug Use For Unknown Indication |
32.3% |
| Product Used For Unknown Indication |
24.5% |
| Drug Abuse |
9.0% |
| Bipolar Disorder |
7.1% |
| Intentional Self-injury |
4.5% |
| Suicide Attempt |
4.5% |
| Epilepsy |
3.9% |
| Poisoning |
2.6% |
| Psychopathic Personality |
2.6% |
| Major Depression |
1.3% |
| Mood Altered |
1.3% |
| Overdose |
1.3% |
| Petit Mal Epilepsy |
1.3% |
| Prophylaxis |
1.3% |
| Status Epilepticus |
1.3% |
| Depression |
0.6% |
| Psychotic Disorder |
0.6% |
|
| Toxicity To Various Agents |
14.7% |
| Respiratory Failure |
8.8% |
| Sopor |
8.8% |
| Vomiting |
8.8% |
| Incorrect Dose Administered |
5.9% |
| Loss Of Consciousness |
5.9% |
| Somnolence |
5.9% |
| Suicide Attempt |
5.9% |
| Convulsion |
2.9% |
| Fall |
2.9% |
| Hyperammonaemia |
2.9% |
| Liver Injury |
2.9% |
| Neutrophil Count Decreased |
2.9% |
| Psychomotor Hyperactivity |
2.9% |
| Rash Erythematous |
2.9% |
| Renal Tubular Disorder |
2.9% |
| Speech Disorder |
2.9% |
| Syncope |
2.9% |
| Tachycardia |
2.9% |
| Tachypnoea |
2.9% |
|
| Secondary |
| Product Used For Unknown Indication |
24.8% |
| Bipolar Disorder |
16.3% |
| Suicide Attempt |
16.3% |
| Drug Use For Unknown Indication |
7.6% |
| Intentional Self-injury |
5.1% |
| Self Injurious Behaviour |
4.6% |
| Drug Abuse |
4.1% |
| Epilepsy |
3.2% |
| Psychopathic Personality |
3.2% |
| Schizophrenia |
3.2% |
| Mental Disorder |
2.8% |
| Intentional Overdose |
1.8% |
| Hypertension |
1.4% |
| Delirium |
0.9% |
| Major Depression |
0.9% |
| Psychotic Disorder |
0.9% |
| Depression |
0.7% |
| Multiple Drug Overdose Intentional |
0.7% |
| Muscle Contractions Involuntary |
0.7% |
| Pain |
0.7% |
|
| Sopor |
22.4% |
| Toxicity To Various Agents |
16.5% |
| Tachycardia |
11.8% |
| Self Injurious Behaviour |
10.6% |
| Suicide Attempt |
5.9% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
3.5% |
| Sluggishness |
3.5% |
| Vomiting |
3.5% |
| Drug Abuse |
2.4% |
| Hyponatraemia |
2.4% |
| Intentional Self-injury |
2.4% |
| Somnolence |
2.4% |
| Speech Disorder |
2.4% |
| Thinking Abnormal |
2.4% |
| Thrombocytopenia |
2.4% |
| Abnormal Weight Gain |
1.2% |
| Agitation |
1.2% |
| Anuria |
1.2% |
| Blood Prolactin Increased |
1.2% |
| Drug Interaction |
1.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
28.4% |
| Psychotic Disorder |
12.8% |
| Depression |
11.5% |
| Epilepsy |
7.8% |
| Bipolar Disorder |
5.5% |
| Mental Retardation |
5.5% |
| Bipolar I Disorder |
3.2% |
| Drug Abuse |
2.3% |
| Hypersensitivity |
2.3% |
| Hypertension |
2.3% |
| Mania |
2.3% |
| Psychomotor Hyperactivity |
2.3% |
| Adjustment Disorder With Depressed Mood |
1.8% |
| Grand Mal Convulsion |
1.8% |
| Myoclonic Epilepsy |
1.8% |
| Post-traumatic Epilepsy |
1.8% |
| Relapsing-remitting Multiple Sclerosis |
1.8% |
| Suicide Attempt |
1.8% |
| Bronchitis |
1.4% |
| Convulsion |
1.4% |
|
| Sopor |
13.6% |
| Platelet Count Decreased |
10.2% |
| Drug Ineffective |
8.5% |
| Toxicity To Various Agents |
8.5% |
| Depersonalisation |
6.8% |
| Tachycardia |
5.1% |
| Amenorrhoea |
3.4% |
| Device Related Infection |
3.4% |
| Grand Mal Convulsion |
3.4% |
| Oedema Peripheral |
3.4% |
| Psychomotor Hyperactivity |
3.4% |
| Psychomotor Retardation |
3.4% |
| Pulmonary Embolism |
3.4% |
| Somnolence |
3.4% |
| Therapeutic Response Unexpected With Drug Substitution |
3.4% |
| Thyroid Cancer |
3.4% |
| Treatment Noncompliance |
3.4% |
| Venous Insufficiency |
3.4% |
| Vomiting |
3.4% |
| Weight Increased |
3.4% |
|
| Interacting |
| Epilepsy |
50.0% |
| Hypersensitivity |
25.0% |
| Transplant |
25.0% |
|
| Epilepsy |
50.0% |
| Vomiting |
50.0% |
|
